ANXA1 and ovarian carcinoma: Secondly, the survival analyses of patients with ovarian cancer clearly indicated that the expression levels of CALR, PDIA3, ANXA1, HMGB1, IFNAR1, and PANX1 had no significant influence on overall survival (OS) and disease-free survival (DFS).